Elevated expression of CD36—a key fatty acid transporter—intensifies tumor cell reliance on the lipid supply from TAMs, and targeting CD36 disrupts fatty acid transfer while inhibiting metabolic adaptation in metastatic tumor cells [61]. Here, CD36 is linked to neoplasm.